InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-22.7%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Tsuchimoto Kim R, Chief Financial Officer. Director active across 1 company, notably Monopar Therapeutics. Aggregated, 18 reports have been published. Regulator: SEC (Form 4). The full history is openly available.
Declarations18 total
9,957 sharesCommon StockSEC:0001437749-24-022024:0
9,956 sharesCommon StockSEC:0001437749-24-010722:0
9,957 sharesCommon StockSEC:0001437749-24-000480:0
9,956 sharesCommon StockSEC:0001437749-23-027587:0
14,846 sharesCommon StockSEC:0001437749-23-019258:0
5,067 sharesCommon StockSEC:0001437749-23-009331:0
5,067 sharesCommon StockSEC:0001437749-23-000166:0
5,066 sharesCommon StockSEC:0001654954-22-013282:0
8,913 sharesCommon StockSEC:0001654954-22-009136:0
1,221 sharesCommon StockSEC:0001654954-22-004489:0
1,231 sharesCommon StockSEC:0001654954-22-000128
1,231 sharesCommon StockSEC:0001654954-22-000128:0
1,221 sharesCommon StockSEC:0001654954-22-000127:0
1,221 sharesCommon StockSEC:0001654954-22-000127
1,221 sharesCommon StockSEC:0001654954-21-010719:0
1,221 sharesCommon StockSEC:0001654954-21-010719
2,442 sharesCommon StockSEC:0001654954-21-007597:0
2,442 sharesCommon StockSEC:0001654954-21-007597
18 of 18 declarations
About Tsuchimoto Kim R
Kim R. Tsuchimoto is the Chief Financial Officer at Monopar Therapeutics. In this role, he is responsible for the financial management of the company, including financial planning and risk management. Tsuchimoto plays a key role in developing financial strategies that support growth and profitability. His expertise in finance and accounting is essential for ensuring transparency and compliance with financial regulations.
